Study in Participants With Acute Migraines Headaches

NCT00804973 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

120

Enrollment

INDUSTRY

Sponsor class

Stopped Due to efficacy results of interim analysis

Conditions

Migraine Headache

Interventions

DRUG: LY2590443
DRUG: Placebo injection
DRUG: Sumatriptan
DRUG: Placebo capsule

Sponsor

Eli Lilly and Company